Abnormal immunophenotype provides a key diagnostic marker: A report of 29 cases of de novo aggressive natural killer cell leukemia

Translational Research

Volumn 163, Issue 6, 2014, Pages 565-577

  Li, Chunrui ^a   Tian, Ye ^a   Wang, Jue ^a   Zhu, Li ^a   Huang, Liang ^a   Wang, Na ^a   Xu, Danmei ^a   Cao, Yang ^a   Li, Jianyong ^b   Zhou, Jianfeng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CD158B ANTIGEN; CD158H ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; KI 67 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; LYMPHOCYTE ANTIGEN; MEMBRANE ANTIGEN; METHOTREXATE; PREDNISONE; UNCLASSIFIED DRUG; VINCRISTINE;

ADOLESCENT; ADULT; AGGRESSIVE NK CELL LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL LABORATORY; CLONAL VARIATION; CONTROLLED STUDY; CYTOGENETICS; DRUG MEGADOSE; EPSTEIN BARR VIRUS; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTIGENS, CD45; FEMALE; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; IMMUNOPHENOTYPING; KI-67 ANTIGEN; KILLER CELLS, NATURAL; LEUKEMIA, LYMPHOID; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, KIR2DL1; RECEPTORS, KIR2DL3; RECEPTORS, KIR3DL1; TOMOGRAPHY, X-RAY COMPUTED; TRANSLATIONAL MEDICAL RESEARCH; TUMOR MARKERS, BIOLOGICAL; VIRAL MATRIX PROTEINS; YOUNG ADULT;

EID: 84901243695     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2014.01.010     Document Type: Article

References (34)

1. N. Villamor, W.G. Morice, W.C. Chan, and K. Foucar Chronic lymphoproliferative disorders of NK-cells S.H. Swerdlow, E. Campo, N.L. Harris, WHO classification of tumours of haematopoietic and lymphoid tissue 4th ed. 2008 IARC Press Lyon, France 274 275
2. J.K.C. Chan, E.S. Jaffe, E. Ralfkiaer, and Y.-H. Ko Aggressive NK-cell leukaemia S.H. Swerdlow, E. Campo, N.L. Harris, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue 4th ed. 2008 IARC Press Lyon, France 276 277
3. J.K.C. Chan, L. Quintanilla-Martinez, J.A. Ferry, and S.C. Peh Extranodal NK/T cell lymphoma, nasal type S.H. Swerdlow, E. Campo, N.L. Harris, WHO classification of tumours of haematopoietic and lymphoid tissue 4th ed. 2008 IARC Press Lyon, France 285 288
4. J. Ryder, X. Wang, L. Bao, S.A. Gross, F. Hua, and R.D. Irons Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature Int J Hematol 85 2007 18 25
5. R. Suzuki, J. Suzumiya, and S. Nakamura et al. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells Leukemia 18 2004 763 770
6. S. Matano, S. Nakamura, and S. Nakamura et al. Monomorphic agranular natural killer cell lymphoma/leukemia with no Epstein-Barr virus association Acta Haematol 101 1999 206 208
7. S.Y. Song, W.S. Kim, Y.H. Ko, K. Kim, M.H. Lee, and K. Park Aggressive natural killer cell leukemia: clinical features and treatment outcome Haematologica 87 2002 1343 1345
8. N. Osuji, E. Matutes, A. Morilla, G.I. Del, A. Wotherspoon, and D. Catovsky Prolonged treatment response in aggressive natural killer cell leukemia Leuk Lymphoma 46 2005 757 763
9. H. Makishima, T. Ito, and N. Asano et al. Significance of chemokine receptor expression in aggressive NK cell leukemia Leukemia 19 2005 1169 1174
10. Y.H. Ko, S. Park, K. Kim, S.J. Kim, and W.S. Kim Aggressive natural killer cell leukemia: is Epstein-Barr virus negativity an indicator of a favorable prognosis? Acta Haematol 120 2008 199 206
11. E.H. Yoo, H.J. Kim, S.T. Lee, W.S. Kim, and S.H. Kim Frequent CD7 antigen loss in aggressive natural killer-cell leukemia: a useful diagnostic marker Korean J Lab Med 29 2009 491 496
12. K. Ino, M. Masuya, and Y. Nakamori et al. [Aggressive NK-cell leukemia with sustained relapse-free survival after allogeneic peripheral blood stem cell transplantation] Rinsho Ketsueki 51 2010 258 263 (in Japanese)
13. E. Takahashi, K. Ohshima, and H. Kimura et al. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders Histopathology 59 2011 660 671
14. F. Ishida, Y.H. Ko, and W.S. Kim et al. Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation Cancer Sci 103 2012 1079 1083
15. N.G. Jiang, Y.M. Jin, Q. Niu, T.T. Zeng, J. Su, and H.L. Zhu Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood Ann Hematol 92 2013 89 96
16. H. Zhang, Q. Meng, W. Yin, L. Xu, and L. Lie Adult aggressive natural killer cell leukemia Am J Med Sci 346 2013 56 63
17. M.B. Lodoen, and L.L. Lanier Viral modulation of NK cell immunity Nat Rev Microbiol 3 2005 59 69
18. L.L. Lanier Evolutionary struggles between NK cells and viruses Nat Rev Immunol 8 2008 259 268
19. W.K. Chan, W.Y. Au, and C.Y. Wong et al. Metabolic activity measured by F-18 FDG PET in natural killer-cell lymphoma compared to aggressive B- and T-cell lymphomas Clin Nucl Med 35 2010 571 575
20. V. Berk, R. Yildiz, and U.O. Akdemir et al. Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: utility of 18F-FDG PET in staging Clin Nucl Med 33 2008 365 366
21. C. Suh, Y.K. Kang, and J.L. Roh et al. Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/T-cell lymphomas of the head and neck J Nucl Med 49 2008 1783 1789
22. T. Derlin, J. Mester, and S. Klutmann F-18 FDG PET/CT findings of aggressive NK-cell leukemia Clin Nucl Med 36 2011 932 933
23. A. Sawada, E. Sato, and M. Koyama et al. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect Am J Hematol 81 2006 576 581
24. P.K. Epling-Burnette, J.S. Painter, and P. Chaurasia et al. Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes Blood 103 2004 3431 3439
25. V. Pascal, N. Schleinitz, and C. Brunet et al. Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions Eur J Immunol 34 2004 2930 2940
26. K. Oshimi Leukemia and lymphoma of natural killer lineage cells Int J Hematol 78 2003 18 23
27. The International Non-Hodgkin's Lymphoma Prognostic Factors Project A predictive model for aggressive non-Hodgkin's lymphoma N Engl J Med 329 1993 987 994
28. A.W. Langerak, P.J. Groenen, and M. Bruggemann et al. EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations Leukemia 26 2012 2159 2171
29. S. Nakamura, T. Suchi, and T. Koshikawa et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract Am J Surg Pathol 19 1995 284 296
30. W.Y. Au, A. Pang, C. Choy, C.S. Chim, and Y.L. Kwong Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients Blood 104 2004 243 249
31. Y. Nakashima, H. Tagawa, and R. Suzuki et al. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type Genes Chromosomes Cancer 44 2005 247 255
32. H.M. Kantarjian, S. O'Brien, and T.L. Smith et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia J Clin Oncol 18 2000 547 561
33. A. Jaccard, N. Gachard, and B. Marin et al. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study Blood 117 2011 1834 1839
34. Y. Mao, D.W. Zhang, and H. Zhu et al. LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL) Diagn Pathol 7 2012 178